About OmniAb, Inc.
https://www.omniab.comOmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics.
CEO
Matthew W. Foehr
Compensation Summary
(Year 2022)
ETFs Holding This Stock
Summary
Showing Top 3 of 81
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
AVISTA CAPITAL HOLDINGS, L.P.
Shares:15.82M
Value:$30.21M
WHITEFORT CAPITAL MANAGEMENT, LP
Shares:14.22M
Value:$27.17M
BLACKROCK INC.
Shares:7.04M
Value:$13.44M
Summary
Showing Top 3 of 153
About OmniAb, Inc.
https://www.omniab.comOmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $2.24M ▼ | $15.72M ▼ | $-16.52M ▼ | -738.05% ▼ | $-0.14 ▲ | $-10.71M ▲ |
| Q2-2025 | $3.9M ▼ | $19.85M ▼ | $-15.88M ▲ | -407.36% ▲ | $-0.15 ▲ | $-14.57M ▼ |
| Q1-2025 | $4.15M ▼ | $23M ▼ | $-18.2M ▼ | -438.13% ▼ | $-0.17 ▼ | $-14.1M ▼ |
| Q4-2024 | $10.8M ▲ | $26.68M ▲ | $-13.07M ▲ | -120.96% ▲ | $-0.12 ▲ | $-8.27M ▲ |
| Q3-2024 | $4.17M | $23.94M | $-16.37M | -392.45% | $-0.16 | $-14.84M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $59.5M ▲ | $309.69M ▲ | $32.25M ▼ | $277.44M ▲ |
| Q2-2025 | $41.62M ▼ | $295.67M ▼ | $33.61M ▲ | $262.06M ▼ |
| Q1-2025 | $43.59M ▼ | $306.18M ▼ | $32.67M ▼ | $273.52M ▼ |
| Q4-2024 | $59.43M ▲ | $325.56M ▼ | $37.94M ▼ | $287.62M ▼ |
| Q3-2024 | $59.38M | $331.55M | $39.83M | $291.73M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-16.52M ▼ | $-9.76M ▼ | $-7.67M ▼ | $27.68M ▲ | $10.26M ▲ | $-9.95M ▼ |
| Q2-2025 | $-15.88M ▲ | $-5.15M ▲ | $12.3M ▲ | $236K ▲ | $7.39M ▲ | $-5.31M ▲ |
| Q1-2025 | $-18.2M ▼ | $-15.87M ▼ | $-878K ▼ | $44K ▼ | $-16.71M ▼ | $-16.08M ▼ |
| Q4-2024 | $-13.07M ▲ | $-3.87M ▲ | $385K ▼ | $3.85M ▼ | $362K ▼ | $-3.92M ▲ |
| Q3-2024 | $-16.37M | $-6.58M | $4.45M | $8.57M | $6.44M | $-6.73M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Royalty | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Service | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
CEO
Matthew W. Foehr
Compensation Summary
(Year 2022)
ETFs Holding This Stock
Summary
Showing Top 3 of 81
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
AVISTA CAPITAL HOLDINGS, L.P.
Shares:15.82M
Value:$30.21M
WHITEFORT CAPITAL MANAGEMENT, LP
Shares:14.22M
Value:$27.17M
BLACKROCK INC.
Shares:7.04M
Value:$13.44M
Summary
Showing Top 3 of 153